Search
Bermuda: Back to Where We Started
Sorcerer II arrived in Bermuda around 7 p.m. on Saturday April 25th after a five day, 1,000 mile sail from Fort Lauderdale, Florida. During the crossing, the crew experienced some challenging weather to say the least. Two samples were collected, and the CTD data confirmed what the J. Craig Venter Institute (JCVI) science team expected: this deep, yet nutrient-poor stretch of open water was very mixed and observed no chlorophyll maximum within 50 meters depth. We are spending...
Q&A with Jessie J. Knight, Jr.
The JCVI CEO Council is a small group of distinguished men and women who are thought leaders in business, medicine, law, the arts and humanities, and community affairs. JCVI is fortunate to have individuals willing to serve as knowledgeable and enthusiastic ambassadors for our scientists and their research, and we are excited to introduce you to our inaugural member, Jessie J. Knight, Jr., Executive Vice President for External Relations at Sempra Energy. Knight is a board member of the...
More than Six Million New Genes, Thousands of New Protein Families, and Incredible Degree of Microbial Diversity Discovered from First Phase of Sorcerer II Global Ocean Sampling Expedition
ROCKVILLE, MD — March 13, 2007 — Researchers from the J. Craig Venter Institute (JCVI) today announced the publication of several studies from the Sorcerer II Global Ocean Sampling Expedition (GOS) in PLoS Biology (www.plosbiology.org) detailing the discovery of millions of new genes, thousands of new protein families and specifically the characterization of thousands of new protein kinases from ocean microbes using whole environment shotgun sequencing and new computational...
Human Longevity Inc. (HLI) Launched to Promote Healthy Aging Using Advances in Genomics and Stem Cell Therapies
SAN DIEGO, March 4, 2014 — Human Longevity Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span, was announced today by co-founders J. Craig Venter, Ph.D., Robert Hariri, M.D., Ph.D., and Peter H. Diamandis, M.D. The company, headquartered in San Diego, California, is being capitalized with an initial $70 million in investor funding. HLI's funding is being used to build the largest human...
World's Leading Genomic Researchers to Gather at 12th International Genome Sequencing and Analysis Conference
PRESS RELEASE World's Leading Genomic Researchers to Gather at 12th International Genome Sequencing and Analysis Conference June 5, 2000 ROCKVILLE, MD -- The Institute for Genomic Research (TIGR) announced today that it will hold its 12th Annual International Genome Sequencing and Analysis Conference (GSAC) on Tuesday, September 12 through Friday, September 15, 2000 at the Fontainebleau Hilton Resort and Towers in Miami, Florida. Recent advances in genomics are the primary focus of...
International Team of Researchers Develops New Tool to Elucidate the Epigenome
MILAN, ITALY — March 24, 2009 — An innovative technology for the rapid and reliable screening of the human epigenome (the set of functional DNA elements that regulate gene state and activity) is being developed by an international team of scientists at the IFOM-IEO Campus in Milan, in collaboration with a group from the J. Craig Venter Institute led by Samuel Levy, Ph.D., and a team from Sangamo BioSciences, Inc., led by Fyodor Urnov. The technology provides a new tool for...
About Hamilton Smith
Hamilton Smith, M.D. is a distinguished professor emeritus at the J. Craig Venter Institute and former director of the Synthetic Biology and Bioenergy Group that created the first synthetic cell in 2010 and designed and synthesized the first minimal bacterial genome in 2016. He received an A.B. degree in Mathematics from the University of California, Berkeley in 1952 and the M.D. degree from the Johns Hopkins School of Medicine in 1956. He completed a residency in Internal Medicine in 1962.
Countdown to GSAC 2000
September 05, 2000 ROCKVILLE, MD - The 2000 Annual Meeting of the International Genome Sequencing and Analysis Conference (GSAC) is nearly upon us. Beginning Tuesday, September 12 through Friday, September 15, nearly 3000 attendees from around the world will gather in Miami Beach, Florida to discuss recent advances in genomics and more. First held in 1989, GSAC has become one of the most unique and important meetings throughout the genome community attracting the world's leading...
Help Take the Bite Out of Cancer
Cancer is one of the most dreaded diseases people face. And oral cancers are some of the most vexing to treat. Oral squamous cell carcinoma or OSCC, a very common type of head and neck cancer, characterized by visible tumor lesions in the mouth, affects more than 450,000 people each year. Approximately 60% of new cases are diagnosed during its later stages when the cancer is already metastatic. These alarming statistics are motivating JCVI researchers to focus their efforts on this disease,...